SG
NVO

StoneX Group’s Novo Nordisk NVO Stock Holding History

StoneX Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,148
Closed -$256K – 902
2024
Q3 		$256K Buy
2,148
+715
+50% +$95.4K 0.11% 254
2024
Q2 		$205K Buy
+1,433
New +$190K 0.1% 302
2021
Q4 		– Sell
-98,554
Closed -$4.73M – 596
2021
Q3 		$4.73M Buy
98,554
+83,504
+555% +$4.04M 0.68% 29
2021
Q2 		$630K Buy
+15,050
New +$583K 0.09% 217
2017
Q3 		– Sell
-22,134
Closed -$475K – 298
2017
Q2 		$475K Buy
+22,134
New +$447K 0.15% 211

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

StoneX Group's NVO Position: Q4 2024 in Review

StoneX Group sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 2,148 shares — an estimated $256K sold.

StoneX Group first reported a position in NVO in Q2 2017 and held it in 5 quarters. The position peaked at $4.73M in Q3 2021. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • StoneX Group reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • StoneX Group sold 2,148 Novo Nordisk shares in Q4 2024, an estimated $256K.
  • StoneX Group first reported a position in Novo Nordisk in Q2 2017 and held it in 5 quarters.
  • StoneX Group's Novo Nordisk position peaked at $4.73M in Q3 2021.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on StoneX Group's 13F filing for Q4 2024, filed 12 Feb 2025.